(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

Composto e composição farmacêutica

DeferidaInvention PatentPCT · US2018056713

Application data

Number

112020007858

Type

Invention Patent

Filing

10/19/2018

Publication

10/27/2020

PCT

US2018056713

Progress at the INPI

Awaiting grant fee payment
  1. Filing10/19/18
  2. Publication10/27/20
  3. Examination
  4. Allowance08/04/26
  5. Grant
  6. In force

The application was allowed by the INPI on 08/04/2026. The grant fee must be paid by 10/03/2026 for the letters patent to be issued.

Deadline to pay the grant fee:10/03/2026(39 days left)

Leave your contact and we will alert you

We track INPI publications and let you know as soon as this case moves.

We use your details only for this alert.

Latest action published by the INPI: 08/04/2026. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

EAGLE RESEARCH LABS LIMITED

MT

Inventors

A. H. (pessoa física)

US

A. L. (pessoa física)

US

C. W. (pessoa física)

US

Technical data

Priority claims

US

62/575,124 · 10/20/2017

US

62/674,422 · 05/21/2018

Abstract

A divulgação refere-se a profármacos de dantroleno, a composições dos mesmos e a métodos para seu uso no tratamento de doenças.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Deferimento

#9.1

08/04/2026

RPI 2900

Exigência - art. 36 da LPI

#6.1

01/27/2026

RPI 2873

Parecer de pré-exame

#6.23

08/23/2022

RPI 2694

Adição na publicação

#15.35

12/07/2021

RPI 2657

Notificação de entrada na fase nacional - PCT

#1.3

10/27/2020

RPI 2599

Alteração de dados cadastrais

#1.1

09/29/2020

RPI 2595

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.